You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
和鉑醫藥-B(02142.HK):巴托利單抗治療全身型重症肌無力試驗獲積極研究結果
阿思達克 03-06 12:12
和鉑醫藥-B(02142.HK)公布,巴托利單抗(HBM9161)治療全身型重症肌無力的III期臨床試驗的積極研究結果。該關鍵臨床研究旨在確認巴托利單抗在治療中國gMG患者時的療效及安全性,是繼2021年8月完成的用於治療中國gMG患者的概念驗證研究取得積極成果之後的又一里程碑。 公司指,正在大中華區開發巴托利單抗,初步專注於重症肌無力、免疫性血小板減少症、視神經脊髓炎譜系疾病、甲狀腺相關性眼病、慢性炎性脫髓鞘性多發性神經根神經病等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account